THE B-CELL TRANSMEMBRANE PROTEIN CD72 BINDS TO AND IS AN IN-VIVO SUBSTRATE OF THE PROTEIN-TYROSINE-PHOSPHATASE SHP-1

Citation
Yj. Wu et al., THE B-CELL TRANSMEMBRANE PROTEIN CD72 BINDS TO AND IS AN IN-VIVO SUBSTRATE OF THE PROTEIN-TYROSINE-PHOSPHATASE SHP-1, Current biology, 8(18), 1998, pp. 1009-1017
Citations number
43
Categorie Soggetti
Biology,Biology
Journal title
ISSN journal
09609822
Volume
8
Issue
18
Year of publication
1998
Pages
1009 - 1017
Database
ISI
SICI code
0960-9822(1998)8:18<1009:TBTPCB>2.0.ZU;2-R
Abstract
Background: Signals from the B-cell antigen receptor (BCR) help to det ermine B-cell fate, directing either proliferation, differentiation, o r growth arrest/apoptosis. The protein tyrosine phosphatase SHP-1 is k nown to regulate the strength of BCR signaling. Although the B-cell co -receptor CD22 binds SHP-1, B cells in CD22-deficient mice are much le ss severely affected than those in SHP-1-deficient mice, suggesting th at SHP-1 may also regulate B-cell signaling by affecting other signali ng molecules, Moreover, direct substrates of SHP-1 have not been ident ified in any B-cell signaling pathway, Results: We identified the B-ce ll transmembrane protein CD72 as a new SHP-1-binding protein and as an in vivo substrate of SHP-1 in B cells. We also defined the binding si tes for SHP-1 and the adaptor protein Grb2 on CD72. Tyrosine phosphory lation of CD72 correlated strongly with BCR-induced growth arrest/apop tosis in B-cell lines and in primary B cells, Preligation of CD72 atte nuated BCR-induced growth arrest/death signals in immature and mature B cells or B-cell lines, whereas preligation of CD22 enhanced BCR-indu ced growth arrest/apoptosis, Conclusions: We have identified CD72 as t he first clear in vivo substrate of SHP-1 in B cells, Our results sugg est that tyrosine-phosphorylated CD72 may transmit signals for BCR-ind uced apoptosis. By dephosphorylating CD72, SHP-1 may have a positive r ole in B-cell signaling, These results have potentially important impl ications for the involvement of CD72 and SHP-1 in B-cell development a nd autoimmunity.